Skip to main content
Premium Trial:

Request an Annual Quote

Biobase to Market Annovar Annotation Tool

NEW YORK (GenomeWeb News) – Biobase today said that it has inked an agreement with the University of Southern California and the Children's Hospital of Philadelphia to exclusively market and distribute their Annovar genomic annotation tool.

The software enables annotation of genomic variants on a variety of specieds including humans, said Beverly, Mass.-based Biobase. It rapidly screens and annotates genetic variants detected with next-generation sequencing platforms on a genome-wide level.

Biobase said that it would sell Annovar as a standalone product and as a complement to its own Genome Trax database of diseases, phenotypes, and functional effects of genomic variants assembled from published results.

"By integrating the annotation functionality of Annovar with the wealth of annotation databases provided by Biobase, users could be getting a boost on their ability to mine functional information from genome variants and accelerate biomedical discoveries," Kai Wang, the developer of Annovar and an assistant professor at the University of Southern California, said in a statement.

Terms of the agreement were not disclosed.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.